Germany consults on new drug pricing mechanism
This article was originally published in Scrip
Executive Summary
Germany's IQWiG, the Institute for Quality and Efficiency in Healthcare, now wants feedback on the results of a study of antidepressants trialling a pricing mechanism, the so called "efficiency frontier method", which could end up being used to determine drug prices after AMNOG pricing disagreements. According to the study, the mechanism has shown that prices of bupropion should be €2.93 rather than the current €104.88, IQWiG told Scrip.